A survey on Malaysian's acceptance and perceptions towards COVID-19 booster dose.

Authors:
Rajakumar S; Shamsuddin N; Alshawsh MA; Rajakumar S; Zaman Huri H.

Journal:
Saudi Pharm J

Publication Year: 2023

DOI:
10.1016/j.jsps.2023.101797

PMCID:
PMC10565867

PMID:
37829192

View on PubMed View on PMC View Publisher
Journal Information

Full Title: Saudi Pharm J

Abbreviation: Saudi Pharm J

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Pharmacology & Pharmacy

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
A comprehensive quality control and cost comparison study of branded and generic angiotensin recept…
Sharma AK; Rastogi S; Ali F and 2 more (2024) - Transparency Score: 3/6
A content-quality and optimization analysis of YouTube as a source of patient information for bipol…
Alsabhan JF; Almalag HM; Abanmy NO and 3 more (2024) - Transparency Score: 4/6
A detailed review of pharmacology of MFN1 (mitofusion-1)-mediated mitochondrial dynamics: Implicati…
Alghamdi A. (2024) - Transparency Score: 2/6
Are drug safety measures harmonized? A real-world evidence from three regulatory authorities.
Alelayan S; Al-Sheikh L; Almotawa R and 2 more (2024) - Transparency Score: 3/6
Chemical profile and biological properties of the <i>Piper corcovadense</i> C.DC. essential oil.
Henrique Fontoura B; Cristina Perin E; Paula Buratto A and 9 more (2024) - Transparency Score: 3/6
View All Papers from This Journal
Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper."

Evidence found in paper:

"Funding No funds, grants, or other support was received for this study."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025